Accu-Chek missiOn: SMBG in Patients With diAbetes on inSulin Study (COMPASS) - Multiple Center, Open, and Non-randomized Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 833 participants.

Also called NCT01130480

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 833 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01130480
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01130480. Allocation not applicable; no masking; primary purpose diagnostic. Start 2010-05-31 (actual); primary completion 2012-03-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Accu-Chek missiOn: SMBG in Patients With diAbetes on inSulin Study (COMPASS) - Multiple Center, Open, and Non-randomized Study
Condition
Diabetes Mellitus Type 2
Intervention (Device)
Accu-Chek Integra Glucometer
Lead sponsor
Hoffmann-La Roche (class: industry)

Record details

Record id
cardio:ct-nct01130480
Content hash
e760aba2179f4e42ccf369e63a31b5a3b309d687191a770fc47c89fe75a43980